Skip to main content
Loading

Current challenges for drug substance CDMOs in the Oligonucleotide space.

21 Jun 2024
Manufacturing
Current challenges for drug substance CDMOs in the Oligonucleotide space.
Industry Expert
Trishul Shah, Director Business Development, Head of Sales North America - PolyPeptide